A Role for Protease Activated Receptor Type 3 (PAR3) in Nociception Demonstrated Through Development of a Novel Peptide Agonist.
Mwirigi J, Kume M, Hassler SN, Ahmad A, Ray PR, Jiang C, Chamessian A, Mseeh N, Ludwig BP, Rivera BD, Nieman MT, Van de Ven T, Ji RR, Dussor G, Boitano S, Vagner J, Price TJ.
Mwirigi J, et al. Among authors: chamessian a.
J Pain. 2021 Jun;22(6):692-706. doi: 10.1016/j.jpain.2020.12.006. Epub 2021 Jan 9.
J Pain. 2021.
PMID: 33429107
Free PMC article.